Fitusiran: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Fitusiran. Educational only — not medical advice.
Labeled uses
QFITLIA is indicated for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients aged 12 years and older with hemophilia A or B with or without factor VIII or IX inhibitors.
Source: FDA labeling via NIH DailyMed (set 6dd2f8ac…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.